Medi Assist Healthcare Services Limited has notified the stock exchanges of an upcoming Board of Directors meeting, pursuant to Regulation 29(1) and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is scheduled for Saturday, May 09, 2026, and will cover key agenda items including the approval of audited financial results and consideration of a final dividend.

Board Meeting Agenda

The Board of Directors meeting on May 09, 2026, has been convened to address the following matters:

• Approval of audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026
• Consideration and recommendation of a final dividend for the financial year 2025-26, if any

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company's internal policy, the trading window for dealing in securities of the Company by Designated Persons and their immediate relatives has been closed from April 1, 2026. The trading window will remain closed until 48 hours after the declaration of the audited financial results for the quarter and financial year ended March 31, 2026.

Q4 & FY26 Earnings Call Details

Medi Assist Healthcare Services has also scheduled an earnings call to discuss the audited financial results. The following table outlines the key details of the call:

Participants are encouraged to pre-register for the call to connect without waiting for operator assistance. Upon registration, participants will receive dial-in numbers, a passcode, and a pin on their registered email address.

Company Representatives on the Call

The following senior management members of Medi Assist Healthcare Services will participate in the earnings call:

The intimation has been signed by Rashmi B V, Company Secretary & Compliance Officer (ICSI Membership No: A38729), and will also be uploaded on the Company's website at www.mediassist.in .

Medi Assist Healthcare Services Limited has received a substantial acquisition disclosure from Massachusetts Institute of Technology (MIT) and 238 Plan Associates LLC after their combined shareholding crossed the 5% regulatory threshold on 29 April 2026.

Share Acquisition Details

The acquisition involved MIT purchasing 38,000 equity shares and 238 Plan Associates LLC acquiring 12,000 equity shares through open market transactions. Both entities are acting as persons acting in concert (PAC) for this investment.

Shareholding Pattern Changes

The acquisition resulted in a significant change in the combined shareholding pattern of both entities:

Regulatory Compliance

The disclosure was filed under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as the combined holding crossed the mandatory 5% threshold. The document was signed by Seth Alexander, President of MIT Investment Management Company, representing both entities as authorized signatory.

Company Share Capital Structure

Medi Assist Healthcare Services Limited maintains a total equity share capital of 74,701,842 equity shares with a face value of INR 5 each, amounting to INR 373,509,210. The company's shares are listed on both the National Stock Exchange of India Limited and BSE Limited.

Investment Background

Neither MIT nor 238 Plan Associates LLC belong to the promoter or promoter group of Medi Assist Healthcare Services Limited. The acquisition represents a strategic investment by these institutional entities in the healthcare services sector through open market purchases.